Literature DB >> 28742884

Reduced expression of E-cadherin and increased sialylation level in clear cell renal cell carcinoma.

Małgorzata Borzym-Kluczyk1, Iwona Radziejewska2, Marzanna Cechowska-Pasko1, Barbara Darewicz3.   

Abstract

Cancer cells are characterized by an aberrant increase in protein N-glycosylation and by disruption of E-cadherin-mediated adherens junctions. However, the relationship between alterations in N-glycosylation process and loss of E-cadherin adhesion in cancer remains unclear. The mechanisms of altered expression of adhesive glycoproteins in cancer cells have not been fully elucidated. Thus, the aim of this study was to examine the expression of E-cadherin and sialyl Lewisa/x, NeuAcα2-3Gal, NeuAcα2-6Gal/GalNAc structures in the normal renal tissue and intermediate and cancerous tissues from patients with clear cell RCC. Moreover, we attempted to correlate the E-cadherin expression with some specific sugar residues of renal cancer tissue glycoproteins. The expression of E-cadherin was analysed using ELISA test and immunoblotting. Oligosaccharide structures and sialylation level were detected with ELISA test using specific biotinylated lectins or antibodies. A significant decrease of E-cadherin expression as well as a significant increase in sialylated oligosaccharides level in intermediate zone and renal cancer tissue in comparison to normal renal tissue are reported. Significant decrease in expression of cadherins and increase in sialylation of oligosaccharide structures in renal cancer tissue in comparison to normal renal tissue, and in renal cancer tissue in comparison to intermediate zone of renal tissue, are important for the future research concerning detection and quantification of cadherins and sialylated oligosaccharide structures in urine and cells of urinary sediment as possible non-invasive marker of early RCC.

Entities:  

Keywords:  E-cadherin; clear cell renal cell carcinoma; lectins; sialyl Lewis antigens

Mesh:

Substances:

Year:  2017        PMID: 28742884     DOI: 10.18388/abp.2015_1215

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  3 in total

Review 1.  Serum sialylation changes in cancer.

Authors:  Zejian Zhang; Manfred Wuhrer; Stephanie Holst
Journal:  Glycoconj J       Date:  2018-04-21       Impact factor: 2.916

Review 2.  Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions.

Authors:  Joyce Lübbers; Ernesto Rodríguez; Yvette van Kooyk
Journal:  Front Immunol       Date:  2018-12-07       Impact factor: 7.561

3.  Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.

Authors:  Yasutaka Yamada; Takayuki Arai; Sho Sugawara; Atsushi Okato; Mayuko Kato; Satoko Kojima; Kazuto Yamazaki; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Cancer Sci       Date:  2018-03-09       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.